Please verify your age.
Legalization skeptics warned that regulated markets would hook a generation of teens. Federal data says otherwise: high-school cannabis use is at its lowest point in three decades, and Germany's first post-legalization survey points the same way. We break down the figures.
Europe's largest medical cannabis exporter spent a year under the microscope after forged export papers sent tonnes astray. At PTMC in Lisbon, Infarmed explained what went wrong, what has changed, and whether 12-day permits can stop supply chains from leaving Portugal.
Only two molecules drive almost every UK cannabis prescription, yet the plant holds more than 100 cannabinoids. We look at why its pharmaceutical potential is still largely untapped, how dosing tolerances stack up, and what better delivery could unlock for patients.
Nine pharmacies, three Swiss cities and 1,177 cannabis users: the SCRIPT trial's interim data shows legal access nudging consumers toward vapes, exposing contaminated street product and raising almost no police concerns. Here's what the numbers mean for growers and regulators.
Europe